Alphagreen Group is a London headquartered business which owns Europe’s largest legal cannabis-based wellness marketplace and is set to become a licensed manufacturer and distributor of medical cannabis products in Germany via its 100% owned subsidiary in Dusseldorf. The marketplace provides a data-driven and curated solution for customers and businesses to order high-quality products directly from brands.

“We’re on a mission to solve daily health issues, eliminate customer confusion and provide access to high quality products. We are building Europe’s leading platform for quality cannabis-based wellness products and medical cannabis. Cannabis Europa gives us a unique opportunity to meet thought leaders in the industry and connect with the top brands in the ecosystem.” — Alexej Pikovsky, CEO and co-founder of Alphagreen


Alphagreen will be joining Cannabis Europa during Prohibition Partners LIVE to share their technology expertise and insight they have as Europe’s leading marketplace. In addition to its curated and data-driven B2C offering, Alphagreen is also launching a B2B solution for CBD shops and the hospitality sector to discover the best products and streamline the ordering process.

The CBD market just in the UK is projected to grow to £1 billion by 2025 and the majority of the purchases will be conducted online. The European market is following that pattern and we will be at the forefront both in the UK and Europe.

The German medical cannabis market is looking to grow to 1 million patients by 2024 with the majority of supply looking to be imported despite planned domestic cultivation. Alphagreen Med GmbH will leverage its global contacts and technology to be a key player in the medical cannabis market in Germany.

Join us on June 22 – 23 to discover the latest developments in the European cannabis sector, learn from our world-renowned speakers, and engage with our network of industry-leading professionals who are pushing boundaries in the cannabis space.